Safety is the most important question anyone should ask before starting a new supplement. Shilajit has been used in traditional medicine for thousands of years and has undergone a meaningful amount of modern safety testing — but the answer to whether it is safe depends significantly on the quality of the product in question. Authentic, purified, third-party-tested shilajit from a high-altitude Himalayan source has a well-supported safety profile. Unverified, unpurified, or contaminated shilajit is a different matter entirely.
This page covers what the research says about shilajit safety, identifies populations who should exercise caution or avoid it, and explains what product standards matter most for safety assurance.
For testing documentation on our product, visit our research and testing page.
What the Research Shows on Safety
Traditional Use Record
Shilajit has been continuously used in Ayurvedic and Tibetan medicine for over 3,000 years. While traditional use does not substitute for controlled clinical trials, this sustained record of use across millions of people provides important epidemiological context. If shilajit caused serious adverse effects at typical therapeutic doses, this would have been documented across its long history of medical use. The absence of significant adverse effect reports in the traditional medical literature is a meaningful safety signal.
Modern Toxicological Data
Acute toxicity studies in animals have consistently shown that purified shilajit has a high margin of safety. A study by Sharma et al. (2003) found no adverse effects at doses far exceeding typical human therapeutic doses in rodent models. Subchronic toxicity studies (90-day administration) have not identified organ toxicity, haematological abnormalities, or histopathological changes in tissues at recommended dose ranges.
Human Clinical Trial Safety Data
Multiple human clinical trials — including the Pandit et al. (2016) testosterone study and the Biswas et al. (2010) sperm quality study — have reported adverse event monitoring as part of their protocols. None reported clinically significant adverse effects at doses of 200–500 mg/day over 90-day periods. The Pandit study explicitly noted that all safety blood markers remained within normal ranges throughout the trial.
The Critical Safety Variable: Product Quality
The most significant safety risk associated with shilajit is not the substance itself but product quality. Raw, unpurified shilajit can contain elevated heavy metals, environmental contaminants, and microbial organisms. Products sold without third-party testing documentation may pose meaningful health risks from chronic exposure to lead, arsenic, mercury, or cadmium at levels above safe thresholds.
This is why heavy metal testing is the non-negotiable safety standard for any shilajit supplement. The specific safety thresholds and testing methodology are covered in detail on our heavy metal testing page. The purification processes that reduce heavy metals are covered on our shilajit purification page.
Who Should Not Use Shilajit
Pregnant and Breastfeeding Women
Shilajit has not been studied in pregnancy or lactation. Given the absence of safety data in these populations, and the general principle of avoiding untested supplements during pregnancy, shilajit is not recommended for pregnant or breastfeeding women.
People with Gout or Hyperuricaemia
Shilajit contains purine compounds, which are metabolised to uric acid in the body. People with gout (uric acid crystal deposits in joints) or elevated uric acid levels should use shilajit cautiously or avoid it, as additional purine intake may worsen their condition.
People with Haemochromatosis
Shilajit contains iron and its fulvic acid may enhance iron absorption. People with haemochromatosis (iron overload disorder) should avoid shilajit or consult their physician, as enhanced iron uptake could worsen iron accumulation.
People with Sickle Cell Anaemia or Thalassaemia
Similar to the above — conditions involving abnormal haemoglobin or red blood cell metabolism may be affected by shilajit’s iron content and mineral delivery properties. Consultation with a healthcare provider is advised.
Anyone Taking Prescription Medications
Shilajit has not been comprehensively studied for drug interactions. Based on its known mechanisms, caution is warranted with blood pressure medications (possible additive hypotensive effects), blood thinners, and medications affecting mineral metabolism. Anyone on prescription medication should consult their healthcare provider before use.
Common Mild Side Effects
For details on reported side effects and how to manage them, see our shilajit side effects page. The most commonly reported mild effects include initial digestive adjustment and occasional sleep disturbance with evening dosing — both manageable by adjusting timing and starting with a lower dose.
Summary: Safe With the Right Product and Precautions
Purified, third-party-tested Himalayan Shilajit from a verified high-altitude source is safe for most healthy adults at recommended doses of 300–500 mg/day. The key variables are product quality (heavy metal compliance, microbial safety), appropriate dosing, and awareness of the specific contraindications listed above.
Our Himalayan Shilajit Resin is tested for all relevant safety parameters by an ISO-accredited third-party laboratory. Full documentation is available via our research and testing page.
References
- Agarwal SP et al. (2007). Shilajit: A review. Phytotherapy Research, 21(5).
- Pandit S et al. (2016). Testosterone in healthy males supplemented with shilajit. Andrologia, 48(5).
- Biswas TK et al. (2010). Spermatogenic activity of shilajit. Andrologia, 42(1).
- Sharma P et al. (2003). Safety evaluation of shilajit. Unpublished — summarised in Agarwal 2007.
